Characterization of extended-spectrum β-lactamases in nosocomial strains of Klebsiella pneumoniae;Caracterización de β-lactamasas de espectro extendido (BLEE) en cepas nosocomiales de K. pneumoniae. Sucre-Venezuela

Investigacion Clinica

Volumn 50, Issue 4, 2009, Pages 419-431

  Guzmán, Militza ^a,b   Alonso, Guillermina ^b  

^a UNIVERSIDAD DE ORIENTE   (Venezuela)

^b FACULTAD DE CIENCIAS   (Venezuela)

Author keywords

Antibiotic resistance; Extended spectrum lactamases; Plasmids

Indexed keywords

AZTREONAM; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; EXTENDED SPECTRUM BETA LACTAMASE; GLUCOSAMINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME ANALYSIS; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PLASMID;

EID: 77949673945     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Essack SY, Hall LM, Pillay D, Mcfadyen M, Livermore D. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum betalactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother 2001; 45:88-95.
2. Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Chistianson S, Simor AE, Paton S and The Canadian Hospital Epidemiology Committee of The Canadian Nosocomial Infection Surveillance Program, Health Canada. Ambler class A extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae spp. in Canadian Hospitals. Antimicrob Agents Chemother 2004; 48: 1204-1214.
3. Sanders CC, Sanders WE. Beta-lactamase in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15:824-839.
4. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14:933-951.
5. Bush K, Jacoby G, Medeiros A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39:1211-1233.
6. Aminoacids sequences for TEM, SHV and OXA extended-spectrium and inhibitor Resistant β-lactamases. (http://www.lahey.org/studies).
7. CTX-M genes. FEMS Microbiol Lett 2004; 234: 201-207.
8. Gobernado M. Betalactamasas de espectro extendido en aumento. Rev Esp Quimioterap 2005; 18-115-117.
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332.
10. Rothaman KJ, Michels KB, Baum M. For and against: Declaración of Helsinki should be strengthened. BMJ 2000; 321: 442-445.
11. era Ed. Editorial Médica Panamericana. Mexico. 1999, p 120-257.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, M100-S18. CLSI 2008. Wayne, PA.
13. Jarlier V, Nicolas M, Fournier G, Philippon A. Extended-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infectol Dis 1988; 10:867-878.
14. Narváez P, Pedroza R, Alonso G, Rodríguez-Lemoine V. Caracterización de plásmidos de resistencia a antibióticos en aislados nosocomiales del Hospital Universitario de Caracas. Rev Soc Venez Microbiol 2005; 25:29-34.
15. Birboim H, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979; 7: 1513-1523.
16. Lesvesque C, Pichel L, Larose C, Roy P. PCR mapping of integron reveals several novel combinationss of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-191.
17. Eckert C, Gautier V, Saladin-Allaard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Philippon A, Arlet G. Dissemination of CTX-M- type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48:1249-1255.
18. Haeggman S, Löfdal S, Poauw A, Verhoef J, Brisse S. Diversity and evolution of the Class A chromosomal Beta-lactamse gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:2400-2408.
19. Eldestein M, Pimkin M, Palagin I, Eldestein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47:3724-3732.
20. Altschul S, Madden T, Schaffer A, Zheng J, Miller W, Lipman D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389-402.
21. Winokur P, Canton R, Casellas M, Legakes N. Variations in the prevalence of strain expressing an extended-spectrum beta-lactmase phenotype and characterization of isolate from Europe, The Americas, and Western Pacific region. Clin Infect Dis 2001; 32:94-103.
22. Schlesinger J, Navon-Venezia S, Chmelnitsky L, Hammer-Munz O, Leavitt A, Gold H, Shwabler M, Carmeli Y. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob Agents Chemother 2001; 49: 1150-1156.
23. Moland E, Black J, Ourada M, Reisbig N, Hanson D, Thomson K. Ocurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. Hospitals. Antimicrob Agents Chemother 2002; 46:3842-3847
24. Heritage J, Chambers P, Tyndall C, Buescher S. SHV-34: an extended-spectrum β-lactamase encoded by an epidemic plasmid. J Antimicrob Chemother 2003; 52:1015-1017.
25. SHV genes on a large conjugative plasmid carried by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Am J Med Sci 2004; 327: 118-122.
26. Essack S, Hall L, Livermore D. Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC β-lactamases. Int J Antimicrob Agents 2004; 23:398-400.
27. Hernández J, Martínez L, Cantón R, Coque T, Pascual A, and The Spanish Group For Nosocomial Infections (GEIH). Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 2005; 49: 2122-2125.
28. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A and the Norwegian ESBL Study Group. Effects of phenotype and genotype on methods for detection of extended-spectrum-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007; 45:199-205.
29. Bush K. New Betalactamases in Gram negative bacteria: Diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32:1085-1089.
30. Yuan M, Hall L, Savelkoul P, Vendenbrouke-Grauls C, Livermore D. SHV-13, a novel Extended-Spectrum β-lactamase, in Klebsiella pneumoniae Isolate from Patients in a Intensive Care Unit in Amsterdam. Antimicrob Agents Chemother 2000; 44: 1081-1084.
31. Araque M, Nieves B, Lauretti L, Rossolini G. Molecular basis of extended-spectrum β-lactamase production in nosocomial isolates of Klebsiella pneumoniae from Mérida, Venezuela. Int J Antimicrob Agents 2000; 15:37-42.
32. Torres L, Gagliotta V, Torres O, Benitez M, Dominguez M, Pedroza R. β-lactamasas de espectro expandido en enterobacterias aisladas en centros de salud de Caracas. Rev Soc Venez Microbiol 2006; 26:80-88.
33. Garza-Ramos U, Martínez-Romero E, Silva-Sánchez J. SHV-type Extended-spectrum β-lactamase (ESBL) are encoded in related plasmids from enterobacteria clinical isolates from Mexico. Salud Publica Mex 2007; 49:415-421.
34. SHV genes in Klebsiella species producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 49:794-77.
35. Kim Y, Pai H, Lee H, Park S, Choi E, Kim J, Kim J, Kim E. Bloodstream infections by Extended-Spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical outcome. Antimicrob Agents Chemother 2002; 46:1481-1491.
36. Vignoli R, Cordeiro N, Seija V, Shelotto F, Radice M, Ayala J, Power P, Gutkind G. Entorno Genético de CTX-M2 em aislamientos de Klebsiella pneumoniae provenientes de pacientes hospitalizados en Uruguay. Rev Argent Microbiol 2006; 38: 84-88.